Intratumor BRAFV600E heterogeneity and kinase inhibitors in the treatment of thyroid cancer: a call for participation. [electronic resource]
Producer: 20130919Description: 517-9 p. digitalISSN:- 1557-9077
No physical items for this record
Publication Type: Letter
There are no comments on this title.
Log in to your account to post a comment.